Well covered elsewhere including a Bloomberg item but for any ABers who have not heard this week’s This American Life I highly recommend it.
The radio newsmagazine offers often whimsical slice of life features along a theme but this week features some very well done journalism in collaboration with ProPublica. A Fed employee records some explosive information from meetings that explain how we are all working for the largest banks one way or another.
“For the first time Tuesday afternoon, there’s new sunshine on the financial ties between drug and device companies and the doctors and teaching hospitals they target to use their products.
Thanks to a bipartisan transparency initiative contained in the 2010 Affordable Care Act, the federal government has compiled a massive database of how much drug and device companies spend on consulting fees, research grants, travel, free lunches and other items worth more than $10.
In just the last five months of 2013, the data show that 4.4 million such payments worth a combined $3.5 billion were made by these companies. Those payments went to 546,000 individual physicians and 1,360 teaching hospitals.”
Well covered elsewhere including a Bloomberg item but for any ABers who have not heard this week’s This American Life I highly recommend it.
The radio newsmagazine offers often whimsical slice of life features along a theme but this week features some very well done journalism in collaboration with ProPublica. A Fed employee records some explosive information from meetings that explain how we are all working for the largest banks one way or another.
http://www.thisamericanlife.org/radio-archives/episode/536/the-secret-recordings-of-carmen-segarra
Another ACA benefit.
“For the first time Tuesday afternoon, there’s new sunshine on the financial ties between drug and device companies and the doctors and teaching hospitals they target to use their products.
Thanks to a bipartisan transparency initiative contained in the 2010 Affordable Care Act, the federal government has compiled a massive database of how much drug and device companies spend on consulting fees, research grants, travel, free lunches and other items worth more than $10.
In just the last five months of 2013, the data show that 4.4 million such payments worth a combined $3.5 billion were made by these companies. Those payments went to 546,000 individual physicians and 1,360 teaching hospitals.”
http://www.washingtonpost.com/blogs/wonkblog/wp/2014/09/30/you-can-now-track-the-billions-that-drug-companies-pay-doctors-and-hospitals/
Sad part is they’ll never find all the cash.